SPARK Impact has expanded in the North West region with the launch of a second office at BioHub at Alderley Park, Cheshire.
The BioHub is situated at Manchester Science Park and was established by AstraZeneca to become the leading bioscience incubator in the North West.
SPARK will join over 68 companies that are already based at the centre including a number of emerging pharmaceutical and life science companies.
Dr Marc d’Abbadie, Investment Director at SPARK Impact, said: “We are pleased to have launched a second office at the BioHub at Alderley Park as this offers the perfect base for us right at the heart of some of the region’s most promising life science companies. The launch of our second office is part of long term growth plan for SPARK as we continue to invest in the very best healthcare technologies in the UK.”